These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18177637)

  • 21. Effect of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus.
    Invernizzi R; Velasco C; Bramante M; Longo A; Samanin R
    Neuropharmacology; 1997; 36(4-5):467-73. PubMed ID: 9225271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pindolol, a putative 5-hydroxytryptamine(1A) antagonist, does not reverse the inhibition of serotonergic neuronal activity induced by fluoxetine in awake cats: comparison to WAY-100635.
    Fornal CA; Martin FJ; Metzler CW; Jacobs BL
    J Pharmacol Exp Ther; 1999 Oct; 291(1):220-8. PubMed ID: 10490908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeated administration of the 5-HT(1B) receptor antagonist SB-224289 blocks the desensitisation of 5-HT(1B) autoreceptors induced by fluoxetine in rat frontal cortex.
    Shalom G; Gur E; Van de Kar LD; Newman ME
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):84-90. PubMed ID: 15309378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of risperidone on the fluoxetine-induced changes in extracellular dopamine, serotonin and noradrenaline in the rat frontal cortex.
    Kamińska K; Gołembiowska K; Rogóż Z
    Pharmacol Rep; 2013; 65(5):1144-51. PubMed ID: 24399710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei.
    Hervás I; Bel N; Fernández AG; Palacios JM; Artigas F
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):315-22. PubMed ID: 9774218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors.
    Gobert A; Millan MJ
    Neuropsychopharmacology; 1999 Aug; 21(2):268-84. PubMed ID: 10432475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucocorticoid receptor antagonists hasten and augment neurochemical responses to a selective serotonin reuptake inhibitor antidepressant.
    Johnson DA; Grant EJ; Ingram CD; Gartside SE
    Biol Psychiatry; 2007 Dec; 62(11):1228-35. PubMed ID: 17651703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modafinil enhances the increase of extracellular serotonin levels induced by the antidepressant drugs fluoxetine and imipramine: a dual probe microdialysis study in awake rat.
    Ferraro L; Fuxe K; Agnati L; Tanganelli S; Tomasini MC; Antonelli T
    Synapse; 2005 Mar; 55(4):230-41. PubMed ID: 15668907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of different challenge doses after repeated citalopram treatment on extracellular serotonin level in the medial prefrontal cortex: in vivo microdialysis study.
    Muraki I; Inoue T; Hashimoto S; Izumi T; Koyama T
    Psychiatry Clin Neurosci; 2008 Oct; 62(5):568-74. PubMed ID: 18950377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of endogenous serotonin-mediated regulation of dopamine release in the rat prefrontal cortex.
    Matsumoto M; Togashi H; Mori K; Ueno K; Miyamoto A; Yoshioka M
    Eur J Pharmacol; 1999 Oct; 383(1):39-48. PubMed ID: 10556679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
    Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA
    Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors.
    Hervás I; Artigas F
    Eur J Pharmacol; 1998 Sep; 358(1):9-18. PubMed ID: 9809863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 5-HT1A antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain.
    Romero L; Hervás I; Artigas F
    Neurosci Lett; 1996 Nov; 219(2):123-6. PubMed ID: 8971795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for accelerated desensitisation of 5-HT(2C) receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat.
    Bristow LJ; O'Connor D; Watts R; Duxon MS; Hutson PH
    Neuropharmacology; 2000 Apr; 39(7):1222-36. PubMed ID: 10760364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain.
    Ortega JE; Gonzalez-Lira V; Horrillo I; Herrera-Marschitz M; Callado LF; Meana JJ
    Eur J Pharmacol; 2013 Jun; 709(1-3):13-9. PubMed ID: 23562616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orienting and defensive behaviors elicited by superior colliculus stimulation in rats: effects of 5-HT depletion, uptake inhibition, and direct midbrain or frontal cortex application.
    Dringenberg HC; Dennis KE; Tomaszek S; Martin J
    Behav Brain Res; 2003 Sep; 144(1-2):95-103. PubMed ID: 12946599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5-HT1A receptor antagonism.
    Dawson LA; Nguyen HQ; Geiger A
    Neuropharmacology; 1999 Aug; 38(8):1153-63. PubMed ID: 10462128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors.
    Weikop P; Kehr J; Scheel-Krüger J
    J Psychopharmacol; 2007 Nov; 21(8):795-804. PubMed ID: 17984160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats.
    Mochizuki D; Tsujita R; Yamada S; Kawasaki K; Otsuka Y; Hashimoto S; Hattori T; Kitamura Y; Miki N
    Psychopharmacology (Berl); 2002 Jul; 162(3):323-32. PubMed ID: 12122491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The selective 5-HT2A receptor antagonist M100907 enhances antidepressant-like behavioral effects of the SSRI fluoxetine.
    Marek GJ; Martin-Ruiz R; Abo A; Artigas F
    Neuropsychopharmacology; 2005 Dec; 30(12):2205-15. PubMed ID: 15886717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.